The effect of urocortin II administration on the coronary circulation and cardiac function in the anaesthetized pig is nitric-oxide-dependent

European Journal of Pharmacology

Volumn 578, Issue 2-3, 2008, Pages 242-248

  Grossini, Elena ^a   Molinari, Claudio ^a   Mary, David A S G ^a   Marino, Paolo ^a   Vacca, Giovanni ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Coronary blood flow; Corticotrophin releasing factor; Myocardial contractility; Nitric oxide; Urocortin II

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UROCORTIN II;

ANESTHESIA; ANIMAL EXPERIMENT; AORTA PRESSURE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; DRUG INFUSION; DRUG MECHANISM; HEART FUNCTION; HEART OUTPUT; HEART RATE; HEART VENTRICLE; HEMODYNAMICS; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; STATISTICAL ANALYSIS; SWINE;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANESTHESIA, GENERAL; ANIMALS; ATROPINE; AUTONOMIC NERVOUS SYSTEM; CARDIAC OUTPUT; CORONARY CIRCULATION; CORONARY VESSELS; ENZYME INHIBITORS; HEART; INFUSIONS, INTRA-ARTERIAL; MUSCARINIC ANTAGONISTS; MYOCARDIAL CONTRACTION; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEPTIDE FRAGMENTS; PHENTOLAMINE; PROPRANOLOL; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; REGIONAL BLOOD FLOW; SUS SCROFA; UROCORTINS; VASODILATION; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 37349056015     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.09.018     Document Type: Article

References (30)

1. Abdelrahman A.M., and Pang C.C. Regional haemodynamic effects of urocortin in the anaesthetized rat. Eur. J. Pharmacol. 466 (2003) 317-321
2. Bale T.L., Hoshijima M., Gu Y., Dalton N., Anderson K.R., Lee K.F., Rivier J., Chien K.R., Vale W.W., and Peterson K.L. The cardiovascular physiologic actions of urocortin II: acute effects in murine heart failure. PNAS 101 (2004) 3697-3702
3. Brar B.K., Jonassen A.K., Egorina E.M., Chen A., Negro A., Perrin M.H., Mjos O.D., Latchman D.S., Lee K.F., and Vale W. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotrophin releasing factor receptor type 2 in the murine heart. Endocrinology 145 (2004) 24-35
4. Burnett J.C. Urocortin: advancing the neurohumoral hypothesis of heart failure. Circulation 112 (2005) 3544-3546
5. Charles C.J., Rademaker M.T., and Richards A.M. Urocortins: putative role in cardiovascular disease. Curr. Med. Chem. Cardiovasc. Hematol. Agents 2 (2004) 43-47
6. Chen Z.W., Huang Y., Yang K., Li X., Wie W., and He G.W. Urocortin-induced relaxation in the human internal mammary artery. Cardiovasc. Res. 65 (2005) 913-920
7. Davis M.E., Pemberton C.J., Yandle T.G., Lainchbury J.G., Rademaker M.T., Nicholls M.G., Frampton C.M., and Richards A.M. Effect of urocortin 1 infusion in humans with stable congestive cardiac failure. Clin. Sci. 109 (2005) 381-388
8. Davis M.E., Pemberton C.J., Yandle T.G., Fisher S.F., Lainchbury J.G., Frampton C.M., Rademaker M.T., and Richards A.M. Urocortin 2 infusion in healthy humans: hemodynamic, neurohormonal, and renal responses. J. Am. Coll. Cardiol. 49 (2007) 461-471
9. Garcia-Villalon A.L., Sanz E., Monge L., Fernandez N., Climent B., and Dieguez G. Urocortin protects coronary endothelial function during ischemia-reperfusion: a brief communication. Exp. Biol. Med. 229 (2004) 118-120
10. Garcia-Villalon A.L., Amezquita Y.M., Monge L., Fernandez N., Climent B., Sanchez A., and Dieguez G. Mechanisms of the protective effects of urocortin on coronary endothelial function during ischemia-reperfusion in rat isolated hearts. Br. J. Pharmacol. 145 (2005) 490-494
11. Gardiner S.M., March J.E., Kemp P.A., Davenport A.P., Wiley K.E., and Bennett T. Regional hemodynamic actions of selective corticotropin-releasing factor type 2 receptor ligands in conscious rats. J. Pharmacol. Exp. Ther. 312 (2005) 53-60
12. Gregory N.G., and Wotton S.B. Autonomic and non-autonomic control of cardiovascular function in stress-sensitive pigs. J. Vet. Pharmacol. Ther. 4 (1981) 183-191
13. Henderson A.H. Endothelium in control. Br. Heart J. 65 (1991) 116-125
14. Huang Y., Chan F.L., Lau C.W., Tsang S.Y., He G.W., Chen Z.Y., and Yao X. Urocortin-induced endothelium-dependent relaxation of rat coronary artery: role of nitric oxide and K+ channels. Br. J. Pharmacol. 135 (2002) 1467-1476
15. Huang Y., Chan F.L., Lau C.W., Tsang S.Y., Chen Z.Y., He G.W., and Yao X. Roles of cyclic AMP and Ca2+-activated K+ channels in endothelium-independent relaxation by urocortin in the rat coronary artery. Cardiovasc. Res. 57 (2003) 824-833
16. Kimura Y., Takahashi K., Totsune K., Muramatsu Y., Kaneko C., Darnel A.D., Suzuki T., Ebina M., Nukiwa T., and Sasano H. Expression of urocortin and corticotrophin releasing factor receptor subtypes in the human heart. J. Clin. Endocrinol. Metab. 87 (2002) 340-346
17. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., Donaldson C., Vaughan J., Reyes T.M., Gulyas J., Fisher W., Bilezikjian L., Rivier J., Sawchenko P.E., and Vale W.W. Identification of urocortin III, an additional member of the corticotrophin-releasing factor (CRF) family with high affinity for the CRF2 receptor. PNAS 98 (2001) 7570-7575
18. Linden R.J., and Mary D.A.S.G. The preparation and maintenance of anaesthetized animals for the study of cardiovascular function. In Life Sciences. In: Linden R.J. (Ed). Techniques in Cardiovascular Physiology (1983), Elsevier Science Publishers, Ireland 1-22
19. Mackay K.B., Stiefel T.H., Ling N., and Foster A.C. Effects of a selective agonist and antagonist of CRF2 receptors on cardiovascular function in the rat. Eur. J. Pharmacol. 469 (2003) 111-115
20. Nishikimi T., Miyata A., Horio T., Yoshihara F., Nagaya N., Takishita S., Yutani C., Matsuo H., Matsuoka H., and Kangawa K. Urocortin, a member of the corticotrophin-releasing factor family, in normal and diseased heart. Am. J. Physiol. Heart. Circ. Physiol. 279 (2000) H3031-H3039
21. Oki Y., and Sasano H. Localization and physiological roles of urocortin. Peptides 25 (2004) 1745-1749
22. Parkes D.G., Vaughan J., Rivier J., Vale W., and May C.N. Cardiac inotropic actions of urocortin in conscious sheep. Am. J. Physiol. 272 (1997) H2115-H2122
23. Rademaker M.T., Cameron V.A., Charles C.J., and Richards M. Integrated hemodynamic, hormonal and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure. Circulation 112 (2005) 3624-3632
24. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A., Hogenesch J.B., Gulyas J., Rivier J., Vale W.W., and Sawchenko P.E. Urocortin II: a member of the corticotrophin-releasing factor (CRF] neuropeptide family that is selectively bound by the type 2 CRF receptors. PNAS 98 (2001) 2843-2848
25. Sanz E., Fernandez N., Monge L., Climent B., Dieguez G., and Garcia-Villalon A.L. Relaxation of rat arteries by urocortin: effects of gender and diabetes. J. Pharm. Pharmacol. 55 (2003) 783-788
26. Terui K., Higashiyama A., Horiba N., Furukawa K.I., Motomura S., and Suda T. Coronary vasodilation and positive inotropism by urocortin in the isolated rat heart. J. Endocrinol. 169 (2001) 177-183
27. Vacca G., Battaglia A., Grossini E., Mary D.A.S.G., Molinari C., and Surico N. The effect of 17β-oestradiol on regional blood flow in anaesthetized pigs. J. Physiol. 514 (1999) 875-884
28. Wiley K.E., and Davenport A.P. CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators. Br. J. Pharmacol. 143 (2004) 508-514
29. Yang L.Z., Kockskamper J., Heinzel F.R., Hauber M., Walther S., Spiess J., and Pieske B. Urocortin II enhances contractility in rabbit ventricular myocytes via CRF2 receptor-mediated stimulation of protein kinase A. Cardiovasc. Res. 69 (2006) 402-411
30. Yao X., He G.W., Chan F.L., Lau C.W., Tsang S.Y., Chen Z.Y., and Huang Y. Endothelium-dependent and- independent coronary relaxation induced by urocortin. J. Card. Surg. 17 (2002) 347-349